Biostats Flashcards

1
Q

Accumulation effect

A

Risk associated w duration of exposure: mom cumulative exp necessary for exp to have a significant effect on risk

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Lead time bias

A

Dx of a disease at an earlier stage = prolongs survival BUT inc survival time d/t early detection

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Observer bias

A

Misclassification of data d/t individual diff or preconceived expectations

Reduced by:

  1. Double-blind study
  2. Multiple observers encode n verify
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Attrition bias

A

Form of selection bias

unequal loss of participants from a randomized controlled trial (RCT).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Allocation vs selection bias

A

Allocation = pts nonrandomy assigned to tx and control grps

Selection = pts not representative of the intended population. eg only cancer pts enrolling in a experimental trial

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Referral / admission rate bias

A

Eg hospital specializing in treating asbestos may report inc relation bw asbestosis and lung ca

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Length-time bias

A

rapidly progressing diseases are less likely to be detected

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Length time vs Lead time bias

A

Length time bias: rapidly progressing diseases less likely to be detected

Lead-time bias: screening leads to inc detection

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Detection bias

A

Pts w RF (eg. Smoking) undergo more testing/ screening

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Preventing bias

A
  1. Double blind studies
  2. Randomized
  3. Placebo
  4. Cross-over studies
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Case-control

A

Measures exposure status

Control - Normal grp

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Study designs

Past:

Present:

Future:

A

Past:

  1. Retrospective cohort : incidence, RF
  2. Case-control: RF frequency, OR

Present:
1. Cross-sectional: Prevalence

Future:

  1. Prospective cohort: RF, incidence
  2. Clinical trial: Tx + control, outcome of interest
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

How is confounding controlled in case-control?

A

Matching

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Cross-sectional study

A

Prevalence study

Exposure and outcome

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Errors

α error:

β error:

1-β:

A

α error: FP
p<0.05

β error: FN
β = 0.2

1-β: Power = 80%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

Prospective cohort

A

Exposed group followed over time for dev of disease

27
Q

OR calculated in?

A

CohORt (uw)

Case-control (FA)

28
Q

Prevalence calculated in

A

Cross-sectional

29
Q

RR calculated in

A

Cohort

30
Q

Precision vs accuracy

A

Precise = how close together it is

Accuracy = how close to the target value

31
Q

RCT

A

Compares Tx

Drug vs placebo

32
Q

Cumulative incidence

A

New cases/ total people at risk @ a specific time

33
Q

ARP

A

ARPexposed = 100 × [(risk in exposed – risk in unexposed)/risk in exposed]

ARP = (RR-1)RR X 100

34
Q

How is the accuracy of screening tests determined?

A

Area under curve (AUC) of receiver operating characteristic (ROC) ~ 1 w/ high SN + SP

35
Q

Test used to compare means of groups

A

ANOVA >3 grp

36
Q

Test used to determines association bw 2 variables

A

Chi-square

37
Q

Test used to compare means of 2 groups

A

T-test

38
Q

Test used to determine the relationship bw 2 variables

A

Correlation coefficient